# The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-adaptive-covid-19-treatment-trial-1-actt-1-in-a-real-world-population-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matilde Grupe Frost,Espen Jimenez‐Solem,Mikkel Zöllner Ankarfeldt,Martin Erik Nyeland,Anne Helms Andreasen,Tonny Studsgaard Petersen |
| Citations | 27 |
| DOI | 10.1186/s13054-020-03406-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://ccforum.biomedcentral.com/counter/pdf/10.1186/s13054-020-03406-3 |
| OpenAlex ID | https://openalex.org/W3113200055 |
| PMID | 33287853 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Martin Erik Nyeland](https://scholariq.org/researchers/martin-erik-nyeland/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.